Multifactorial Approach Associated With Orlistat (Xenical) for 4 Years Weight Loss Maintenance in Obese Adults
NCT02706067
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
DRUG:
Orlistat
Sponsor
Hoffmann-La Roche